by John Conrad | Jan 19, 2023 | Member News
As Horizon ties up the loose ends for its $28 billion sale to Amgen, a drug it picked up from a previous acquisition of its own is delivering a mid-stage win. Horizon had already declared Phase II success for dazodalibep among one group of patients with Sjögren’s...
by John Conrad | Jan 12, 2023 | Member News
In the wake of Evozyne’s hiring of a seasoned tech-company executive as CEO, the Chicago-based biotech company announced it’s developed an AI model that it hopes will revolutionize development of new therapeutic proteins, significantly accelerating the...
by John Conrad | Dec 1, 2022 | Member News
Whether it’s the need to upgrade equipment, relocate or liquidate an entire facility, ALT can develop a customized solution – so you get the greatest ROI possible! Benefits include: 20% discount on surplus services 10% bonus on standard consignment split 10% rebate on...
by John Conrad | Nov 18, 2022 | Member News
State-funded program provides matching grants to small businesses who have received federal SBIR/STTR funding to support entrepreneurship, commercialization, and innovation CHICAGO – Governor Pritzker and the Illinois Department of Commerce and Economic...
by John Conrad | Nov 3, 2022 | Member News
Northwestern University’s Querrey InQbation Lab hosted its inaugural event, “Synthetic Biology 2.0 | What Comes Next,” on October 26th, featuring panels and “lakeside chats” focused on opportunities in this important area. The day highlighted panelists and speakers...
